Blue Owl Capital's high permanent capital base and strong fee growth should support consistent earnings across market cycles.

Avoid letting politics dictate investment decisions. Click here to find out how to maintain a disciplined cash management ...

There is no guarantee that FDA will accept the NDA for Anaphylm. The therapeutic area is crowded, though Anaphylm has several ...

Antero Midstream offers stable, fee-based cash flows with minimal commodity price exposure. Read why AM stock is a Hold.

Adobe's AI adoption and recurring revenue growth remain positive. Click here to read why I have a buy rating on ADBE stock.

For the quarter ended March 31, 2025, the SMA outperformed the Index on a gross-of-fees basis due to favorable stock ...

Prem Watsa’s 13F portfolio grew to $1.84B in Q1 2025. Check out Fairfax Financial Holdings' top holdings and strategic stake ...

Broadcom's AI business is growing rapidly but remains a small portion of its $1.2T valuation. Click here to read why AVGO ...

Only nine private equity-backed IPOs have launched in Europe and the U.S. this year, a dramatic fall from 116 during the same stretch in 2021. Big names like Permira and EQT have already opted for ...

Ashland’s asset sales and buybacks haven’t boosted per-share growth amid shrinking sales, earnings and rising debt. See why ...

What are the best tech hardware stocks right now for investors? Seeking Alpha analysts offer their picks. Read more here.

Backlog surges 55%, nuclear opportunities grow, and margins improve. Attractive valuation with a CAD 22 target.